General Comments / Chat, page-3516

RAC would need to have a market cap well over AUD $1.2B to have a chance of entry to ASX300 as from memory it needs to rank above the 24th-lowest position (whilst also having market cap higher than other contenders for entry). There are also other liquidity requirements.

I added RAC in a new SMSF earlier in the year. From memory it took me about 8 weeks to set it up and complete the rollovers.

I actually think it is better for RAC to achieve ASX300 entry in the March 2022 rebalance. That gives time for strong results from trials and preclinical activities.

Next ASX300 rebalance announcement will be early September.